Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xenopharm is a South Korean biotechnology company specializing in animal health, diagnostics, and advanced research in xenotransplantation. The company develops and manufactures a variety of rapid diagnostic kits for critical livestock diseases, such as Foot and Mouth Disease (FMD) and Porcine Reproductive and Respiratory Syndrome (PRRS). In addition to its diagnostic portfolio, Xenopharm is involved in the development of animal vaccines and bio-materials. A core focus of its long-term research is xenotransplantation, where it utilizes transgenic pig models to develop organs and tissues suitable for human transplantation. Xenopharm aims to improve global health outcomes by advancing the fields of veterinary diagnostics and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xenopharm.